Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study

References

• Turner J. Hypercalcaemia – presentation and management. Clin Med (Lond). 2017;17(3):270–273.
   PubMed Web of Science ®Google Scholar
• Minisola S, Pepe J, Piemonte S, et al. The diagnosis and management of hypercalcaemia. BMJ. 2015;350:h2723.
   PubMedGoogle Scholar
• Asban A, Dombrowsky A, Mallick R, et al. Failure to diagnose and treat hyperparathyroidism among patients with hypercalcemia: opportunities for intervention at the patient and physician level to increase surgical referral. Oncologist. 2019;24(9):e828–e834.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Kuraganti G, Steenkamp D. Hypercalcemic crisis: a clinical review. Am J Med. 2015;128(3):239–245.
   PubMed Web of Science ®Google Scholar
• Ziegler R. Hypercalcemic crisis. J Am Soc Nephrol: JASN. 2001;12(Suppl 17):S3–S9.
   PubMedGoogle Scholar
• Wang CA, Guyton SW. Hyperparathyroid crisis: clinical and pathologic studies of 14 patients. Ann Surg. 1979;190(6):782–790.
   PubMed Web of Science ®Google Scholar
• Starker LF, Bjorklund P, Theoharis C, et al. Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis. World J Surg. 2011;35(2):331–335.
   PubMed Web of Science ®Google Scholar
• Bentata Y, El Maghraoui H, Benabdelhak M, et al. Management of hypercalcaemic crisis in adults: Current role of renal replacement therapy. Am J Emerg Med. 2018;36(6):1053–1056.
   PubMed Web of Science ®Google Scholar
• Yu N, Donnan PT, Leese GP. A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf). 2011;75(2):169–176.
   PubMed Web of Science ®Google Scholar
• Hagstrom E, Kilander L, Nylander R, et al. Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts. J Clin Endocrinol Metab. 2014;99(11):4181–4189.
   PubMed Web of Science ®Google Scholar
• Maier JD, Levine SN. Hypercalcemia in the intensive care unit: a review of pathophysiology, diagnosis, and modern therapy. J Intensive Care Med. 2015;30(5):235–252.
   PubMed Web of Science ®Google Scholar
• Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561–3569.
   PubMed Web of Science ®Google Scholar
• Ariyan CE, Sosa JA. Assessment and management of patients with abnormal calcium. Crit Care Med. 2004;32(4 Suppl):S146–S154.
   PubMed Web of Science ®Google Scholar
• Camus C, Charasse C, Jouannic-Montier I, et al. Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia. Intensive Care Med. 1996;22(2):116–121.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
   Web of Science ®Google Scholar
• Yoon BR, Leem AY, Park MS, et al. Optimal timing of initiating continuous renal replacement therapy in septic shock patients with acute kidney injury. Sci Rep. 2019;9(1):11981.
   Google Scholar
• Au S, Dunham M, Godinez T. Treatment of medically refractory hypercalcemic crisis. Int J Artif Organs. 2012;35(7):538–541.
   PubMed Web of Science ®Google Scholar
• Kindgen-Milles D, Kram R, Kleinekofort W, et al. Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation. ASAIO J. 2008;54(4):442–444.
   PubMed Web of Science ®Google Scholar
• Gradwohl-Matis I, Franzen M, Seelmaier C, et al. Renal replacement therapy with regional citrate anticoagulation as an effective method to treat hypercalcemic crisis. ASAIO J. 2015;61(2):219–223.
   PubMed Web of Science ®Google Scholar
• Sramek V, Novak I, Matejovic M, et al. Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia. Intensive Care Medicine. 1998;24(3):262–264.
   PubMed Web of Science ®Google Scholar
• Fernandez SN, Santiago MJ, Lopez-Herce J, et al. Citrate anticoagulation for CRRT in children: comparison with heparin. Biomed Res Int. 2014;2014:786301.
   PubMed Web of Science ®Google Scholar
• Wu MY, Hsu YH, Bai CH, Lin YF, et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;59(6):810–818.
   PubMed Web of Science ®Google Scholar
• Bai M, Zhou M, He L, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098–2110.
   PubMed Web of Science ®Google Scholar
• Stucker F, Ponte B, Tataw J, et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care. 2015;19:91.
   PubMed Web of Science ®Google Scholar
• Kindgen-Milles D, Brandenburger T, Dimski T. Regional citrate anticoagulation for continuous renal replacement therapy. Curr Opin Crit Care. 2018;24(6):450–454.
   PubMed Web of Science ®Google Scholar
• Huguet M, Rodas L, Blasco M, et al. Clinical impact of regional citrate anticoagulation in continuous renal replacement therapy in critically ill patients. Int J Artif Organs. 2017;40(12):676–682.
   PubMed Web of Science ®Google Scholar
• Wang PL, Meyer MM, Orloff SL, et al. Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. Am J Kidney Dis. 2004;44(6):1110–1114.
   PubMed Web of Science ®Google Scholar
• Klingele M, Seiler S, Poppleton A, et al. The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss – a case report. BMC Nephrol. 2014;15:163.
   PubMed Web of Science ®Google Scholar
• Chen XM. Blood purification standard operating precedure (SOP). Beijing, China: People's Army Medical Publishing House. 2019.
   Google Scholar
• Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, et al. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration. Ther Apher Dial. 2011;15(6):556–564.
   PubMed Web of Science ®Google Scholar
• Ricci D, Panicali L, Facchini MG, et al. Citrate anticoagulation during continuous renal replacement therapy. Contribut Nephrol. 2017;190:19–30.
   PubMed Web of Science ®Google Scholar
• Khadzhynov D, Schelter C, Lieker I, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29(2):265–271.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med. 2012;38(1):20–28.
   PubMed Web of Science ®Google Scholar
• Uchino S, Fealy N, Baldwin I, et al. Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med. 2003;29(4):575–578.
   PubMed Web of Science ®Google Scholar
• Oudemans-van Straaten HM, Bosman RJ, Koopmans M, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med. 2009;37(2):545–552.
   PubMed Web of Science ®Google Scholar
• Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61(5):649–672.
   PubMed Web of Science ®Google Scholar
• Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Crit Care. 2011;15(1):202.
   PubMed Web of Science ®Google Scholar